Patents by Inventor Catherine Fowler

Catherine Fowler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 5-POSITION MODIFIED PYRIMIDINES AND THEIR USE
    Publication number: 20190233461
    Abstract: The present disclosure relates to the field of nucleic acid chemistry, specifically to 5-position modified uridines as well as phosphoramidite and triphosphate derivatives thereof. The present disclosure also relates to methods of making and using the same.
    Type: Application
    Filed: January 22, 2019
    Publication date: August 1, 2019
    Inventors: John Rohloff, Nebojsa Janjic, Jeffrey D. Carter, Catherine Fowler
  • 5-position modified pyrimidines and their use
    Patent number: 10221207
    Abstract: The present disclosure relates to the field of nucleic acid chemistry, specifically to 5-position modified uridines as well as phosphoramidite and triphosphate derivatives thereof. The present disclosure also relates to methods of making and using the same.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: March 5, 2019
    Assignee: SomaLogic, Inc.
    Inventors: John Rohloff, Nebojsa Janjic, Jeffrey D. Carter, Catherine Fowler
  • 5-POSITION MODIFIED PYRIMIDINES AND THEIR USE
    Publication number: 20180127450
    Abstract: The present disclosure relates to the field of nucleic acid chemistry, specifically to 5-position modified uridines as well as phosphoramidite and triphosphate derivatives thereof. The present disclosure also relates to methods of making and using the same.
    Type: Application
    Filed: July 14, 2017
    Publication date: May 10, 2018
    Inventors: John Rohloff, Nebojsa Janjic, Jeffrey D. Carter, Catherine Fowler
  • 5-POSITION MODIFIED PYRIMIDINES AND THEIR USE
    Publication number: 20160355540
    Abstract: The present disclosure relates to the field of nucleic acid chemistry, specifically to 5-position modified uridines as well as phosphoramidite and triphosphate derivatives thereof. The present disclosure also relates to methods of making and using the same.
    Type: Application
    Filed: April 4, 2016
    Publication date: December 8, 2016
    Inventors: John Rohloff, Nebojsa Janjic, Jeffrey D. Carter, Catherine Fowler
  • 5-POSITION MODIFIED PYRIMIDINES AND THEIR USE
    Publication number: 20150376223
    Abstract: The present disclosure relates to the field of nucleic acid chemistry, specifically to 5-position modified uridines as well as phosphoramidite and triphosphate derivatives thereof. The present disclosure also relates to methods of making and using the same.
    Type: Application
    Filed: September 8, 2015
    Publication date: December 31, 2015
    Inventors: John Rohloff, Nebojsa Janjic, Jeffrey D. Carter, Catherine Fowler
  • 5-position modified pyrimidines and their use
    Patent number: 9163056
    Abstract: The present disclosure relates to the field of nucleic acid chemistry, specifically to 5-position modified uridines as well as phosphoramidite and triphosphate derivatives thereof. The present disclosure also relates to methods of making and using the same.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: October 20, 2015
    Assignee: SomaLogic, Inc.
    Inventors: John Rohloff, Nebojsa Janjic, Jeffrey D. Carter, Catherine Fowler
  • 5-POSITION MODIFIED PYRIMIDINES AND THEIR USE
    Publication number: 20140058076
    Abstract: The present disclosure relates to the field of nucleic acid chemistry, specifically to 5-position modified uridines as well as phosphoramidite and triphosphate derivatives thereof. The present disclosure also relates to methods of making and using the same.
    Type: Application
    Filed: November 1, 2013
    Publication date: February 27, 2014
    Inventors: John Rohloff, Nebojsa Janjic, Jeffrey D. Carter, Catherine Fowler
  • 5-POSITION MODIFIED PYRIMIDINES AND THEIR USE
    Publication number: 20110275794
    Abstract: The present disclosure relates to the field of nucleic acid chemistry, specifically to 5-position modified uridines as well as phosphoramidite and triphosphate derivatives thereof. The present disclosure also relates to methods of making and using the same.
    Type: Application
    Filed: April 12, 2011
    Publication date: November 10, 2011
    Applicant: SomaLogic, Inc.
    Inventors: John Rohloff, Nebojsa Janjic, Jeffrey D. Carter, Catherine Fowler